Hepatitis: Global eradication of hepatitis B-feasible or fallacy?

Nature Reviews Gastroenterology and Hepatology

Volumn 9, Issue 9, 2012, Pages 492-494

  Thursz, Mark ^a   Njie, Ramatoulie ^b   Lemoine, Maud ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ARTICLE; DRUG EFFICACY; ERADICATION THERAPY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HEPATITIS B; HUMAN; IMMUNIZATION; INCIDENCE; INFECTION CONTROL; MORTALITY; PREVALENCE; PRIORITY JOURNAL; TAIWAN; VERTICAL TRANSMISSION; WORLD HEALTH ORGANIZATION;

DISEASE ERADICATION; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; TAIWAN; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 84865775456     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2012.155     Document Type: Article

References (10)

1. WHO. Hepatitis B. WHO [online], http://www.who.int/csr/disease/hepatitis/ HepatitisB-whocdscsrlyo2002-2.pdf (2002).
2. Aggarwal, R., Ghoshal, U. C. & Naik, S. R. Assessment of cost-effectiveness of universal hepatitis B immunization in low-income country with intermediate endemicity using a Markov Model. J. Hepatol. 38, 215-222 (2003). (Pubitemid 36169632)
3. Ni, Y. H. et al. Minimization of hepatitis B infection by a 25-year universal vaccination program. J. Hepatol. http://dx.doi.org/10.1016/j.jhep. 2012.05.021.
4. Ott, J. J., Stevens, G. A., Groeger, J. & Wiersma, S. T. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 30, 2212-2219 (2012).
5. Edmunds, W. J. et al. Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas. Epidemiol. Infect. 117, 313-325 (1996). (Pubitemid 26345241)
6. Chen, H. L. et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology 142, 773-781 (2012).
7. van der Sande, M. A. et al. Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence. PLoS ONE 2, e753 (2007).
8. WHO. The Smallpox Eradication Programme. WHO [online], http://www.who.int/features/2010/smallpox/en (2010).
9. Goldstein, S. T. et al. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int. J. Epidemiol. 34, 1329-1339 (2005). (Pubitemid 41819540)
10. Thursz, M., Cooke, G. S. & Hall, A. J. Hepatitis B treatment in resource poor settings: time for action. Trop. Med. Int. Health 15, 2-4 (2010).